<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>chronic granulomatous disease &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chronic-granulomatous-disease/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:21:56 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>chronic granulomatous disease &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Gene Editing Enables cDNA Therapy for Chronic Granulomatous Disease</title>
		<link>https://bioengineer.org/gene-editing-enables-cdna-therapy-for-chronic-granulomatous-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 12 Aug 2025 23:36:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cDNA insertion]]></category>
		<category><![CDATA[chronic granulomatous disease]]></category>
		<category><![CDATA[CRISPR-Cas9 gene therapy]]></category>
		<category><![CDATA[hematopoietic stem cell editing]]></category>
		<category><![CDATA[immune function restoration]]></category>
		<guid isPermaLink="false">https://bioengineer.org/gene-editing-enables-cdna-therapy-for-chronic-granulomatous-disease/</guid>

					<description><![CDATA[In a groundbreaking development that could redefine treatments for chronic granulomatous disease (CGD), researchers have unveiled a highly innovative gene editing strategy aimed at restoring immune function through precise genetic modifications. Published recently in Nature Communications, this pioneering work leverages the power of targeted gene editing combined with near-universal cDNA insertion of the two critical [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">255325</post-id>	</item>
	</channel>
</rss>
